CuraScientific Corp. (CSTF) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
51544 CESAR CHAVEZ STREET, COACHELLA, CA 92236 |
| State of Incorp. | OK |
| Fiscal Year End | December 31 |
| Industry (SIC) | 289 - Miscellaneous Chemical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 0 | 23 | |||
| Cash and cash equivalents | 0 | 23 | |||
| Receivables | 17 | ||||
| Inventory, net of allowances, customer advances and progress billings | 8 | ||||
| Inventory | 8 | ||||
| Capitalized contract cost | |||||
| Other undisclosed current assets | 40 | 79 | |||
| Total current assets: | 40 | 127 | |||
| Noncurrent Assets | |||||
| Operating lease, right-of-use asset | |||||
| Property, plant and equipment | 87 | 88 | |||
| Other undisclosed noncurrent assets | 1,425 | 2,025 | |||
| Total noncurrent assets: | 1,512 | 2,113 | |||
| TOTAL ASSETS: | 1,552 | 2,240 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 330 | 113 | |||
| Accounts payable | 330 | 113 | |||
| Debt | 2,637 | 1,059 | |||
| Due to related parties | ✕ | 104 | |||
| Other undisclosed current liabilities | 67,738 | 70,455 | |||
| Total current liabilities: | 70,810 | 71,627 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 250 | ||||
| Due to related parties | ✕ | 250 | |||
| Operating lease, liability | |||||
| Other undisclosed noncurrent liabilities | |||||
| Total noncurrent liabilities: | 250 | ||||
| Total liabilities: | 71,060 | 71,627 | |||
| Equity | |||||
| Equity, attributable to parent, including: | (69,508) | (69,387) | |||
| Common stock | 333 | 40 | |||
| Additional paid in capital | (54,287) | (58,490) | |||
| Retained earnings (accumulated deficit) | (16,454) | (11,186) | |||
| Other undisclosed equity, attributable to parent | 900 | 250 | |||
| Total equity: | (69,508) | (69,387) | |||
| TOTAL LIABILITIES AND EQUITY: | 1,552 | 2,240 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Revenues | 34 | 86 | ||
| Cost of revenue | (13) | (31) | ||
| Gross profit: | 22 | 55 | ||
| Operating expenses | (2,402) | (4,832) | ||
| Other undisclosed operating loss | ||||
| Operating loss: | (2,380) | (4,776) | ||
| Nonoperating income (expense) | (2,888) | (1,094) | ||
| Interest and debt expense | 1,827 | 134 | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (1,827) | (134) | ||
| Income (loss) from continuing operations: | (5,268) | (5,870) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (5,870) | |
| Net income (loss) available to common stockholders, diluted: | (5,268) | (5,870) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Net income (loss): | (5,268) | (5,870) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (5,268) | (5,870) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.